trade fundament data
upsid target
click enter text
decemb publish report claim mrk gardasil
like substanti under-model analyst stem
analysi gap gardasil revenu estim meaning go
continu grow
compar consensu global pharmaceut
model billion dollar webinar present see slide
note unusu see year-old product suddenli
sit front increas momentum pharmaceut product
would near end patent live point vaccin
effect gener paradigm worri instead vaccin
like slowli grow perpetu gardasil case
almost competit either market develop
cite four renew growth driver gardasil roll-out new
geographi china major contributor gradual expans
age patient elig
recommend say girl boy receiv vaccin
broader awar gardasil prevent sever cancer beyond
cervic cancer caus hpv infect
product
brief updat show consensu estim gradual
catch exhibit consensu gardasil estim
higher time report risen
gardasil estim continu higher
matter stori often investor view
keytruda real driver growth keytruda import
overst gardasil on-going contribut also remain critic
keytruda eventu goe off-pat late gardasil like
continu rate outperform inform
stock cover see juli issu
factset/wolf research price august
report limit sole use client wolf research pleas refer disclosur section locat end
report analyst certif import disclosur disclosur
page
exhibit show gardasil estim time re-initi coverag
public gardasil deep dive current estim gardasil chang materi
sinc decemb step-up order out-year
exhibit wr estim pre- post- gardasil report step-up
page
exhibit show consensu gardasil estim evolv last sinc report
continu rise awar broader opportun gardasil grow sinc decemb consensu
estim higher current estim shown refer still roughli
higher current consensu
exhibit gardasil consensu estim progress vs wr current estim gap close
page
